Evidence map›Paper›PMID 34705246›Full record

ArticleFrontiers of medicine2022

Effectiveness of quality of care for patients with type 2 diabetes in China: findings from the Shanghai Integration Model (SIM).

Chun Cai, Yuexing Liu, Yanyun Li, Yan Shi, Haidong Zou, Yuqian Bao, Yun Shen, Xin Cui, Chen Fu, Weiping Jia and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Frontiers of medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Diabetes care in China: Innovations and implications.Journal of diabetes investigation · 2022
    Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chun Cai *Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, National Office for Primary Diabetes Care, Shanghai Technical Center for Diabetes Prevention and Clinical Care, Shanghai Key Laboratory of Diabetes Mellitus, Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai, 200233, China.
Yuexing Liu *Shanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, National Office for Primary Diabetes Care, Shanghai Technical Center for Diabetes Prevention and Clinical Care, Shanghai Key Laboratory of Diabetes Mellitus, Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai, 200233, China.
Yanyun LiShanghai Municipal Center for Disease Control & Prevention, Shanghai, 200336, China.
Yan ShiShanghai Municipal Center for Disease Control & Prevention, Shanghai, 200336, China.
Haidong ZouShanghai Eye Disease Prevention and Treatment Center/Shanghai Eye Hospital, Shanghai Key Laboratory of Ocular Fundus Diseases; Shanghai General Hospital, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai, 200040, China.
Yuqian BaoShanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, National Office for Primary Diabetes Care, Shanghai Technical Center for Diabetes Prevention and Clinical Care, Shanghai Key Laboratory of Diabetes Mellitus, Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai, 200233, China.
Yun ShenShanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, National Office for Primary Diabetes Care, Shanghai Technical Center for Diabetes Prevention and Clinical Care, Shanghai Key Laboratory of Diabetes Mellitus, Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai, 200233, China.
Xin CuiShanghai Municipal Health Commission Information Center, Shanghai, 200040, China.
Chen FuShanghai Municipal Center for Disease Control & Prevention, Shanghai, 200336, China. fuchen@scdc.sh.cn.
Weiping JiaShanghai Diabetes Institute, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, National Office for Primary Diabetes Care, Shanghai Technical Center for Diabetes Prevention and Clinical Care, Shanghai Key Laboratory of Diabetes Mellitus, Department of Endocrinology and Metabolism, Shanghai Clinical Center for Diabetes, Shanghai Key Clinical Center for Metabolic Disease, Shanghai, 200233, China. wpjia@sjtu.edu.cn.
SIM Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This cross-sectional study aimed to investigate the quality of care of diabetes in Shanghai, China. A total of 173 235 patients with type 2 diabetes in 2017 were included in the analysis. Profiles of risk factors and intermediate outcomes were determined. The patients had a mean age of 66.43 ± 8.12 (standard deviation (SD)) years and a mean diabetes duration of 7.95 ± 5.53 (SD) years. The percentage of patients who achieved the target level for HbA

Indexed as

Diabetes Mellitus, Type 2AgedBlood PressureChinaCholesterol, LDLCross-Sectional StudiesGlycated HemoglobinHumansMaleMiddle AgedCholesterol, LDLGlycated Hemoglobinepidemiologymacrovascular complicationmicrovascular complicationquality of caretreatment patterntype 2 diabetes

Identifiers

PMID34705246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.